Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuanta Investment is a leading South Korean venture capital and private equity firm that plays a significant role in the Asian life sciences ecosystem. As a subsidiary of Yuanta Securities, the firm manages a diverse range of investment funds focused on high-potential sectors, including biotechnology, healthcare, and medical technology. Yuanta Investment provides capital across various stages of company growth, from early-stage startups to late-stage enterprises seeking expansion or IPO. Their healthcare portfolio features a wide array of companies working on innovative therapeutics, diagnostics, and healthcare IT solutions. The firm is recognized for its expertise in navigating the Korean regulatory and financial markets to support the commercialization of medical innovations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuanta Investment.